---
figid: PMC6317954__CAS-110-23-g004
figlink: /pmc/articles/PMC6317954/figure/cas13849-fig-0004/
number: F4
caption: Mechanisms of metformin combined with Abs or small molecular inhibitors in
  cancer treatment. Metformin activates the adenosine monophosphate activated protein
  kinase (AMPK) pathway, eventually causing inhibition of the mTOR pathway. Metformin
  also indirectly reduces Akt activation, through insulin‐mediated insulin receptor
  (IR) and the insulin‐like growth factor‐1 receptor (IGF‐1R)/IR hybrid which activates
  the PI3/Akt/mTOR and RAS/RAF/MAPK/ERK pathways. These pathways are also inactivated
  by Abs or small molecule inhibitors. Thus, metformin shows synergy with targeted
  drugs to reduce protein synthesis and cellular proliferation. EGFR, epidermal growth
  factor receptor; HER2, human epidermal growth factor receptor 2; IGF‐1, insulin‐like
  growth factor‐1; IRS, insulin/insulin‐like growth factor‐1 receptor substrate; Shc,
  Src homology 2/alpha‐collagen related protein; VEGFR, vascular endothelial growth
  factor receptor
pmcid: PMC6317954
papertitle: Novel application of metformin combined with targeted drugs on anticancer
  treatment.
reftext: Jun Deng, et al. Cancer Sci. 2019 Jan;110(1):23-30.
pmc_ranked_result_index: '39992'
pathway_score: 0.9741034
filename: CAS-110-23-g004.jpg
figtitle: Metformin combined with Abs or small molecular inhibitors in cancer treatment
year: '2019'
organisms: Homo sapiens
ndex: 5b4176f5-dec2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6317954__CAS-110-23-g004.html
  '@type': Dataset
  description: Mechanisms of metformin combined with Abs or small molecular inhibitors
    in cancer treatment. Metformin activates the adenosine monophosphate activated
    protein kinase (AMPK) pathway, eventually causing inhibition of the mTOR pathway.
    Metformin also indirectly reduces Akt activation, through insulin‐mediated insulin
    receptor (IR) and the insulin‐like growth factor‐1 receptor (IGF‐1R)/IR hybrid
    which activates the PI3/Akt/mTOR and RAS/RAF/MAPK/ERK pathways. These pathways
    are also inactivated by Abs or small molecule inhibitors. Thus, metformin shows
    synergy with targeted drugs to reduce protein synthesis and cellular proliferation.
    EGFR, epidermal growth factor receptor; HER2, human epidermal growth factor receptor
    2; IGF‐1, insulin‐like growth factor‐1; IRS, insulin/insulin‐like growth factor‐1
    receptor substrate; Shc, Src homology 2/alpha‐collagen related protein; VEGFR,
    vascular endothelial growth factor receptor
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - IRS2
  - ARAF
  - MAPK3
  - MAPK8
  - MAPK14
  - EIF4EBP1
  - AKT3
  - PIK3CG
  - PIK3R3
  - ERBB2
  - IGF1
  - IGF1R
  - IRS1
  - IRS4
  - PIK3R6
  - PIK3R5
  - PIK3R4
  - MAPK11
  - PRKAA2
  - EGFR
  - MAPK12
  - MAP2K1
  - MAP2K2
  - MTOR
  - RPS6KB1
  - RPS6KB2
  - KRAS
  - NRAS
  - AKT1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - SHC1
  - FLT1
  - FLT4
  - KDR
  - RAF1
  - BRAF
  - HRAS
  - PRKAA1
  - SHC3
  - MAPK10
  - AKT2
  - SHC2
  - MAPK9
  - MAPK13
  - SHC4
  - Metformin
  - XGefitinib
  - Sorafenib
  - Everolimus
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: /IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: IR/IGF-IR
  symbol: IGFIR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: AMPKA
  symbol: AMPK_alpha
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: AMPKA
  symbol: AMPK_alpha
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
chemicals:
- word: Metformin
  source: MESH
  identifier: D008687
- word: XGefitinib
  source: ''
  identifier: ''
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: Everolimus
  source: MESH
  identifier: C107135
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6317954__F4
redirect_from: /figures/PMC6317954__F4
figtype: Figure
---
